New momentum in research offers hope for people living with lupus Story May 15, 2026 Since she was 8 years old, Nancy Mize Gonzalez dreamed of becoming a concert pianist. She practiced for hours...
Join the Lupus Research Alliance for the Walk with Us to Cure Lupus May 9 at New Jersey’s Meadowlands Racetrack Press Release May 4, 2026 The Lupus Research Alliance (LRA) will unite dedicated lupus champions for the New Jersey Walk with Us to Cure...
Lupus Research Alliance Showcases Hope in Action this Lupus Awareness Month Press Release May 1, 2026 The Lupus Research Alliance, the world’s largest private funder of lupus research, today announced a series of initiatives in...
Lupus Research Alliance Announces New Lupus Innovation Award Recipients to Advance Understanding of Lupus Press Release April 28, 2026 Six recipients were selected for their novel projects that will help improve lupus diagnosis and treatment Today, the Lupus Research...
Saphnelo™ Approved as Self-Administered Autoinjector News Update April 27, 2026 The U.S. Food and Drug Administration just granted approval for a self-administered, once-weekly autoinjector of Saphenlo (anifrolumab), for the...
Debbie Schwartz: Advocating in Every Sense of the Word Story April 27, 2026 Debbie Schwartz is absolutely convinced that a cure for lupus will be found in her lifetime. Why? Because she’s...
The Lupus Research Alliance and Rheumatology Research Foundation Commit $1.9M to Empower Early-Career Scientists Press Release April 2, 2026 Leading rheumatology research organizations unite to support the research workforce and fuel lupus breakthroughs. Today, the Lupus Research Alliance (LRA),...
New Phase 2 Data Showed that Litifilimab Significantly Reduced Disease Activity in Cutaneous Lupus Erythematosus News Update March 30, 2026 The Lupus Research Alliance welcomes new results from the Phase 2 part of the AMETHYST Phase 2/3 study, showing...
Faith Majors: Living with Lupus and Refusing to Give Up Story March 24, 2026 The stats are all too familiar – nine out of ten people with lupus are women. During Women’s History...
New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly Reduces Lupus Disease Activity in SLE News Update March 6, 2026 A new Phase 3 study published in the New England Journal of Medicine found that Gazyva® (obinutuzumab) significantly reduced...
Clinical Affiliate Lupus Therapeutics Expands Peer-to-Peer Program News Update February 24, 2026 New Centralized Model to Include Hundreds of Research Sites Across North America The clinical affiliate of the Lupus Research Alliance,...
Meet Kendra Latigue: How Learning, Sharing, and a PAL Brought Inspiration Story February 24, 2026 From the first time Kendra Latigue shared her lupus diagnosis on social media, she was surprised to find true...